scispace - formally typeset
M

Mark A. Mintun

Researcher at Washington University in St. Louis

Publications -  246
Citations -  50518

Mark A. Mintun is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Positron emission tomography & Alzheimer's disease. The author has an hindex of 91, co-authored 230 publications receiving 47308 citations. Previous affiliations of Mark A. Mintun include University of Kansas & University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers.

TL;DR: The positron emission tomography 18F-fluorodeoxyglucose (18FDG) method is used to examine the fenfluramine-induced changes in regional cerebral glucose metabolism (rCMRglu) to study abnormalities of serotonin function in the prefrontal cortex.
Journal ArticleDOI

Type 2 diabetes mellitus, brain atrophy, and cognitive decline

Chris Moran, +253 more
- 19 Feb 2019 - 
TL;DR: In an older cohort with low cerebrovascular disease burden, T2DM contributes to cognitive decline via neurodegeneration in older people with normal cognition, mild cognitive impairment, and Alzheimer disease.
Journal ArticleDOI

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states

Ines Mahjoub, +241 more
- 07 Mar 2018 - 
TL;DR: This work uses structural T1-w MRI to define morphological brain networks, and uses this architecture to discover morphological connectional biomarkers fingerprinting the difference between late MCI and AD stages, which included the right entorhinal cortex and right caudal middle frontal gyrus.
Journal ArticleDOI

Relationship of dementia screening tests with biomarkers of Alzheimer’s disease

TL;DR: The AD8 had superior sensitivity in detecting early stages of dementia compared with the Mini Mental State Examination and may improve strategies for detecting dementia in community settings where biomarkers may not be readily available, and may enrich clinical trial recruitment by increasing the likelihood that participants have underlying biomarker abnormalities.
Journal ArticleDOI

Regulation of blood flow in activated human brain by cytosolic NADH/NAD+ ratio

TL;DR: In awake human subjects, it is shown that by transiently raising blood pyruvate concentration during local increases in functional brain activity, a maneuver designed to reduce the cytosolic NADH/NAD+ ratio, the expected blood flow response measured with positron-emission tomography is significantly attenuated.